The American Association for Cancer Research (AACR) welcomed David A. Tuveson, MD, PhD, FAACR, as President of the organization for 2021–2022. He was inaugurated during the AACR Annual Business Meeting, held virtually on April 12.
Dr. Tuveson is Director of the Cold Spring Harbor Laboratory Cancer Center in Cold Spring Harbor, New York, where he is also the Roy J. Zuckerberg Professor of Cancer Research. Additionally, he is Chief Scientist for the Lustgarten Foundation in Woodbury, New York.
Dr. Tuveson is a also medical staff affiliate at Memorial Sloan Kettering Cancer Center in New York, and he works closely with the Cancer Institute at Northwell Health on Long Island. Additionally, Dr. Tuveson serves on the Board of Scientific Advisors of the National Cancer Institute. He is a physician-scientist whose basic and translational research focuses on the biology of pancreatic cancer and on identification of new approaches for diagnosing and treating the disease.An AACR member since 2003, Dr. Tuveson served on the Board of Directors from 2018 to 2020.
David A. Tuveson, MD, PhD, FAACR
Lisa M. Coussens, PhD, FAACR
Other New Roles
Lisa M. Coussens, PhD, FAACR, Associate Director for Basic Research at the Knight Cancer Institute, Professor and Chair of the Cell, Developmental, and Cancer Biology Department, and Hildegard Lamfrom Endowed Chair in Basic Science at Oregon Health & Science University, was inducted as the AACR President-Elect for 2021–2022. Antoni Ribas, MD, PhD, FAACR, Professor of Medicine, Surgery, and Molecular and Medical Pharmacology at the University of California, Los Angeles (UCLA), and Director of the UCLA Jonsson Comprehensive Cancer Center Tumor Immunology Program, will now serve as immediate Past President.
